158 related articles for article (PubMed ID: 38065835)
1. The evolving spectrum of human African trypanosomiasis.
Kennedy PGE
QJM; 2024 Jun; 117(6):391-395. PubMed ID: 38065835
[TBL] [Abstract][Full Text] [Related]
2. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
3. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
4. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
[TBL] [Abstract][Full Text] [Related]
5. African sleeping sickness.
Hedley L; Fink D; Sparkes D; Chiodini PL
Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
[No Abstract] [Full Text] [Related]
6. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
[TBL] [Abstract][Full Text] [Related]
7. The continuing problem of human African trypanosomiasis (sleeping sickness).
Kennedy PG
Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506
[TBL] [Abstract][Full Text] [Related]
8. Control and surveillance of human African trypanosomiasis.
World Health Organization
World Health Organ Tech Rep Ser; 2013; (984):1-237. PubMed ID: 24552089
[TBL] [Abstract][Full Text] [Related]
9. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
[TBL] [Abstract][Full Text] [Related]
10. Killer coma: the evolving story of sleeping sickness treatment.
Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
[No Abstract] [Full Text] [Related]
11. Treatment options for second-stage gambiense human African trypanosomiasis.
Eperon G; Balasegaram M; Potet J; Mowbray C; Valverde O; Chappuis F
Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1407-17. PubMed ID: 25204360
[TBL] [Abstract][Full Text] [Related]
12. In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
Schmid C; Kuemmerle A; Blum J; Ghabri S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete D; Mubwa N; Kisala M; Blesson S; Mordt OV
PLoS Negl Trop Dis; 2012; 6(11):e1920. PubMed ID: 23209861
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for second-stage human African trypanosomiasis.
Lutje V; Seixas J; Kennedy A
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
[TBL] [Abstract][Full Text] [Related]
15. NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.
Yun O; Priotto G; Tong J; Flevaud L; Chappuis F
PLoS Negl Trop Dis; 2010 May; 4(5):e720. PubMed ID: 20520803
[No Abstract] [Full Text] [Related]
16. The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020.
Franco JR; Cecchi G; Paone M; Diarra A; Grout L; Kadima Ebeja A; Simarro PP; Zhao W; Argaw D
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010047. PubMed ID: 35041668
[TBL] [Abstract][Full Text] [Related]
17. A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness").
Sutherland CS; Yukich J; Goeree R; Tediosi F
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003397. PubMed ID: 25654605
[TBL] [Abstract][Full Text] [Related]
18. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
19. The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets.
Franco JR; Priotto G; Paone M; Cecchi G; Ebeja AK; Simarro PP; Sankara D; Metwally SBA; Argaw DD
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012111. PubMed ID: 38626188
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for second-stage human African trypanosomiasis: drugs in use.
Lutje V; Probyn K; Seixas J; Bergman H; Villanueva G
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD015374. PubMed ID: 34882307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
